EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drugs Repurposing of Molecules Modulating Human Delta Globin Gene Expression via a Model of Transgenic Foetal Liver Cells: Implications for Beta-Hemoglobinopathy Therapeutics

Michela Simbula, Maria Francesca Manchinu iD, Stefania Olla iD, Michela Congiu, Simona Vaccargiu, Cristian Antonio Caria iD, Daniela Poddie, Maria Serafina Ristaldi iD

Biomolecules · 2025

DOI: 10.3390/biom15040565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Michela Simbula und 7 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Di Ricerca Genetica e Biomedica del Consiglio Nazionale Delle Ricerche (IRGB-CNR), 09042 Monserrato, Italy. Hauptthemen laut MEDLINE: Drug Repositioning, delta-Globins, beta-Thalassemia, Hemoglobinopathies. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Telethon Foundation, Fondazione Telethon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beta-hemoglobinopathies such as beta-thalassemia and sickle cell disease are severe genetic blood disorders affecting the beta globin chain of haemoglobin A (α2β2). Activation of delta globin, the non-alpha globin of HbA2 (α2δ2), could represent a possible approach to improve the clinical severity of these pathologies. Notably, the therapeutic potential of delta globin has been demonstrated in previous studies using a mouse model of beta-thalassemia and sickle cell disease. The present study evaluated delta globin gene activation by small molecules in erythroid cells isolated from transgenic murine foetal liver. A screening of 119 molecules, selected for their potential in drug repurposing, was performed without prior selection based on specific pathways of interest. Three candidates—Nexturastat, Stattic and Palbociclib—were found to have high efficacy on delta globin expression. Palbociclib also proved effective in increasing gamma globin expression. All of these compounds have pharmacokinetic profiles that are beneficial for clinical application, providing potential inducer agents of HbA2 that could have therapeutic effects in the treatment of beta-hemoglobinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Repositioningdelta-Globinsbeta-ThalassemiaHemoglobinopathiesAnimalsHumansMiceMice, TransgenicPyridinesLiverPiperazinesGene Expression Regulation

Stichwörter der Autor:innen

beta-thalassemiadelta globin genedrug assaysickle cell disease

Substanzen

delta-GlobinsPyridinespalbociclibPiperazines

Autor:innen und Institutionen

  • Istituto Di Ricerca Genetica e Biomedica del Consiglio Nazionale Delle Ricerche (IRGB-CNR), 09042 Monserrato, Italy.

ORCID-Profile: Maria Francesca Manchinu, Stefania Olla, Cristian Antonio Caria, Maria Serafina Ristaldi

Förderung

  • Telethon Foundation
  • Fondazione Telethon

Zitieren

APA

Simbula, M., Manchinu, M. F., Olla, S., Congiu, M., Vaccargiu, S., Caria, C. A., Poddie, D., & Ristaldi, M. S. (2025). Drugs Repurposing of Molecules Modulating Human Delta Globin Gene Expression via a Model of Transgenic Foetal Liver Cells: Implications for Beta-Hemoglobinopathy Therapeutics. Biomolecules. https://doi.org/10.3390/biom15040565

Vancouver

Simbula M, Manchinu MF, Olla S, Congiu M, Vaccargiu S, Caria CA, et al. Drugs Repurposing of Molecules Modulating Human Delta Globin Gene Expression via a Model of Transgenic Foetal Liver Cells: Implications for Beta-Hemoglobinopathy Therapeutics. Biomolecules. 2025. doi:10.3390/biom15040565

BibTeX
@article{Simbula2025,
  author = {Simbula, Michela and Manchinu, Maria Francesca and Olla, Stefania and Congiu, Michela and Vaccargiu, Simona and Caria, Cristian Antonio and Poddie, Daniela and Ristaldi, Maria Serafina},
  title = {Drugs Repurposing of Molecules Modulating Human Delta Globin Gene Expression via a Model of Transgenic Foetal Liver Cells: Implications for Beta-Hemoglobinopathy Therapeutics},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15040565}
}
Kostenlos starten →